Another medication, Orlistat (Xenical and over-the-counter Alli) is a lipase inhibitor not a GLP-1 and differs from the other medications in that it works for obesity management by preventing the absorption of fat in the gastrointestinal tract
Weight loss varies from person to person, but clinical studies suggest that individuals may lose between 5% to 10% of their body weight in the first 1216 weeks when combined with lifestyle changes
Perkey, E., Fingar, D., Miller, R
GLP-1 Users Enjoy Solo Dining However, those with current, past, or intended experience using GLP-1 medications for weight loss are more than four times as likely as those who have never tried GLP-1s to say they dine in at restaurants by themselves at least weekly
For the relatively small percentage of people who experience persistent, severe dry mouth despite all interventions, dose reduction or medication change remains an option